In two studies among patients with coronary artery disease, it reduced the concentrations of pro-inflammatory interleukins (ILs) 8 and 12; interferons, including interferon gamma (IFN-γ); and IL-1β [80,81]. The gene discussed is IL1B; the disease is coronary artery disorder.